Skip to main content
Log in

Commentary on “physiologically based pharmacokinetic modeling as a tool for drug development”

  • Perspectives in Pharmacokinetics
  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. S. B. Charnick, R. Kawai, J. R. Nedelman, M. Lemaire, W. Niederberger, and H. Sato. Physiologically based pharmacokinetic modeling as a tool for drug development.J. Pharmacokin. Biopharm.23:213–225.

  2. D. Verotta, L. B. Sheiner, W. F. Ebling, and D. R. Stanski. A semiparametric approach to physiological flow models.J. Pharmacokin. Biopharm. 17:463–491 (1989).

    Article  CAS  Google Scholar 

  3. D. Verotta, L. B. Sheiner, and S. L. Beal. Mean time parameters for generalized physiological flow models (semihomogeneous linear systems).J. Pharmacokin. Biopharm. 19:319–331 (1991).

    Article  CAS  Google Scholar 

  4. W. F. Ebling, D. R. Wada, and D. R. Stanski. From piecewise to full physiologic modeling: Applied to thiopental disposition in the rat.J. Pharmacokin. Biopharm. 22:259–292 (1994).

    Article  CAS  Google Scholar 

  5. F. Y. Bois, A. Gelman, J. Jiang, D. R. Maszle, L. Zeise, and G. Alexeef. Population toxicokinetics of tetrachloroethylene. OEHHA Technical Report, CAL/EPA (1995).Arch. Toxicol. (submitted)

Download references

Author information

Authors and Affiliations

Authors

Additional information

The opinions presented in this article are those of the authors and do not represent the views or policies of the Food and Drug Administration.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ludden, T.M., Gillespie, W.R. & Bachman, W.J. Commentary on “physiologically based pharmacokinetic modeling as a tool for drug development”. Journal of Pharmacokinetics and Biopharmaceutics 23, 231–235 (1995). https://doi.org/10.1007/BF02354274

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02354274

Keywords

Navigation